Hospital
Baptist Medical Center of the Beaches, INC
Baptist Medical Center of the Beaches, INC was paid $3.21M by Medicaid between Jan 2018 and Oct 2023, across 107 billing codes. Its largest line is 96361, Intravenous infusion, hydration; each additional hour — 20% of everything it billed.
33Billing provider infoBAPTIST MEDICAL CENTER OF THE BEACHES, INC
JACKSONVILLE BEACH, FL 32250
JACKSONVILLE BEACH, FL 32250
33aNPI1821155912assigned 01/02/2007
33bProvider typeGeneral Acute Care Hospital
28Total paid$3.21M
24GClaims122,094
24DCodes billed107
24AFirst – last monthJan 2018 – Oct 2023
Compared with peers
Next to other General Acute Care Hospital providers in Florida
Rank by total paid#104 of 163
Median peer was paid$4.77M
This provider vs. median0.7×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 12,476 | $186K | |
| 2019 | 30,548 | $781K | |
| 2020 | 23,377 | $507K | |
| 2021 | 25,772 | $698K | |
| 2022 | 25,539 | $834K | |
| 2023 | 4,382 | $203K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 96361 | Intravenous infusion, hydration; each additional hour | 20% | 3,373 | 2,471 | $635K |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 18% | 6,730 | 5,105 | $566K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 17% | 4,865 | 3,650 | $531K |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 11% | 5,977 | 4,704 | $365K |
| 80048 | Basic metabolic panel (calcium, ionized) | 4.7% | 7,765 | 5,039 | $150K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 3.8% | 837 | 639 | $121K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 3.5% | 1,970 | 1,510 | $114K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 3.5% | 1,421 | 1,098 | $111K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 2.4% | 4,195 | 3,080 | $78K |
| 80053 | Comprehensive metabolic panel | 2.0% | 3,667 | 2,752 | $64K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 1.7% | 459 | 352 | $56K |
| 70450 | Computed tomography, head or brain; without contrast material | 1.6% | 1,787 | 1,348 | $53K |
95 more codes
| 81025 | <1% | 3,439 | $30K | |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | <1% | 1,366 | $29K |
| G0378 | Hospital observation service, per hour | <1% | 1,000 | $28K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 751 | $21K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 10,772 | $19K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 360 | $17K |
| 36415 | Collection of venous blood by venipuncture | <1% | 2,377 | $15K |
| 59025 | Fetal non-stress test | <1% | 255 | $13K |
| 87631 | <1% | 331 | $11K | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 881 | $8K |
| 71045 | Radiologic examination, chest; single view | <1% | 3,680 | $8K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 115 | $8K |
| 81001 | <1% | 4,631 | $7K | |
| 84484 | <1% | 3,916 | $7K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 4,073 | $7K |
| 80305 | <1% | 1,370 | $7K | |
| 87088 | <1% | 2,533 | $7K | |
| 86901 | <1% | 418 | $7K | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 2,636 | $6K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 2,133 | $6K |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 3,095 | $6K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 361 | $6K |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 183 | $6K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 616 | $6K |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 1,232 | $6K |
| 99205 | Prolong outpt/office vis | <1% | 106 | $5K |
| 85610 | <1% | 2,154 | $5K | |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | <1% | 366 | $5K |
| 80076 | <1% | 3,370 | $5K | |
| 80061 | Lipid panel | <1% | 505 | $4K |
| 99217 | <1% | 99 | $4K | |
| 87430 | <1% | 544 | $4K | |
| 83690 | <1% | 2,745 | $3K | |
| 85730 | <1% | 1,674 | $3K | |
| 81003 | <1% | 1,391 | $3K | |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 122 | $3K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 62 | $3K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 84 | $2K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 1,212 | $2K |
| 87081 | <1% | 143 | $2K | |
| 82962 | <1% | 279 | $2K | |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 100 | $2K |
| 82150 | <1% | 724 | $2K | |
| 83880 | <1% | 653 | $2K | |
| 87210 | <1% | 471 | $2K | |
| 83735 | <1% | 1,322 | $2K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 1,991 | $1K |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 1,509 | $1K |
| 99218 | <1% | 95 | $915.45 | |
| 84702 | <1% | 176 | $767.11 | |
| 73630 | <1% | 16 | $758.72 | |
| 87040 | <1% | 232 | $718.22 | |
| 83605 | <1% | 521 | $701.42 | |
| 84704 | <1% | 114 | $592.54 | |
| 85027 | <1% | 32 | $504.04 | |
| 93976 | <1% | 62 | $486.85 | |
| 87801 | Infectious agent detection by nucleic acid; amplified probe, multiple organisms | <1% | 366 | $391.50 |
| 93971 | <1% | 16 | $351.02 | |
| 87186 | <1% | 73 | $318.86 | |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 100 | $293.65 |
| J2704 | Injection, propofol, 10 mg | <1% | 89 | $278.15 |
| 87077 | <1% | 93 | $263.59 | |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 37 | $219.34 |
| J2550 | Injection, promethazine hcl, up to 50 mg | <1% | 54 | $163.65 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 338 | $125.97 |
| 85652 | <1% | 47 | $86.02 | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 56 | $81.66 |
| 74018 | <1% | 17 | $77.32 | |
| 85379 | <1% | 214 | $60.48 | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 77 | $56.86 |
| 82550 | <1% | 429 | $50.59 | |
| 82565 | <1% | 168 | $44.26 | |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | <1% | 61 | $22.10 |
| 80051 | <1% | 150 | $15.91 | |
| 96376 | <1% | 95 | $15.86 | |
| 80320 | 0% | 93 | $0.00 | |
| 76830 | Ultrasound, transvaginal | 0% | 12 | $0.00 |
| J2060 | Injection, lorazepam, 2 mg | 0% | 35 | $0.00 |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 0% | 80 | $0.00 |
| 82553 | 0% | 53 | $0.00 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 0% | 38 | $0.00 |
| 90674 | 0% | 12 | $0.00 | |
| 82607 | 0% | 16 | $0.00 | |
| Q0162 | Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | 0% | 80 | $0.00 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 0% | 39 | $0.00 |
| 87205 | 0% | 15 | $0.00 | |
| 84520 | 0% | 153 | $0.00 | |
| 82947 | 0% | 153 | $0.00 | |
| 93017 | 0% | 19 | $0.00 | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 0% | 80 | $0.00 |
| 84100 | 0% | 16 | $0.00 | |
| 82248 | 0% | 71 | $0.00 | |
| 82310 | 0% | 150 | $0.00 | |
| 86900 | 0% | 23 | $0.00 | |
| J1650 | Injection, enoxaparin sodium, 10 mg | 0% | 32 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialBOYCE, PHILIP (CHIEF REVENUE OFFICER)
| Provider | Location | Paid |
|---|---|---|
| Southern Baptist Hospital of Florida INC | Jacksonville, FL | $87.92M |
| Southern Baptist Hospital of Florida, INC | Jacksonville, FL | $3.49M |
| Baptist Medical Center of Nassau INC | Fernandina Beach, FL | $3.46M |
| Southern Baptist Hospital of Florida, INC | Jacksonville, FL | $3.32M |
| Southern Baptist Hospital of Florida, INC | Fleming Island, FL | $1.70M |
| Southern Baptist Hospital of Florida, INC | Jacksonville, FL | $1.30M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.